Publication information
About Longevity Ranked and The Compound
Longevity Ranked is a comparison publication in The Compound portfolio, published by Arsenal Productions SRL. We help readers understand NAD+ and sermorelin offers before beginning a provider's clinical assessment. Our first job is concrete: make the product, the bill and the uncertainty understandable in one place.
Why NAD+ and sermorelin under one brand?
Longevity is the market and reader interest; it is not a molecule. NAD+ is a coenzyme, while sermorelin is a peptide. They are covered in separate guides and comparisons so a broad brand does not erase those differences. Inclusion is not a claim that a product extends life. See the distinction.
Who writes and is responsible for the publication?
The byline “Longevity Ranked editorial team” identifies The Compound's publishing work. Arsenal Productions SRL is the publisher. These pages are source-based editorial comparisons; they do not imply that a named doctor, pharmacist or medical-review board has reviewed or endorsed them.
Our contact address is thecompoundgroupco@gmail.com. The methodology explains what we verified and what we did not.
How does this relate to GLP-1 Picks and HRT Picks?
They are separate publications in the same portfolio, with their own specialist reader journeys. GLP-1 Picks focuses on weight-management care. HRT Picks covers hormone care, including its HRT and TRT paths. Shared ownership does not make the treatments interchangeable or transfer an affiliate approval between websites.
See The Compound for the portfolio.
What should you not use this site for?
Do not use these comparisons to self-prescribe, choose a dose, combine treatments or replace medical care. Prices are not personal quotes and a provider listing is not an unconditional endorsement. For a symptom, adverse reaction, prescription or urgent concern, use an appropriate clinical service rather than this publication's inbox.